Resonance Health Limited (RHT)

Overview

Resonance Health Limited is a pioneering healthcare technology and services company that operates across the globe, including in the Asia Pacific, North America, Europe, the Middle East, and Africa. Founded in 1987, the company is dedicated to the design, development, manufacture, and commercialization of innovative software-as-medical devices. Resonance Health is headquartered in Burswood, Australia, and strives to contribute to the medical and pharmaceutical fields by offering a range of non-invasive diagnostic and analytical tools that utilize advanced technologies such as artificial intelligence (AI) and MRI. Their solutions cater to clinicians managing various human diseases and support pharmaceutical and therapeutic companies in conducting clinical trials.

Products and Services

• FerriScan: A non-invasive MRI based system that quantifies liver iron concentration (LIC), offering a critical tool for diagnosing and managing conditions related to iron accumulation in the liver.
• FerriSmart: An AI-assisted device designed for the automated real-time assessment of LIC, facilitating quicker and more efficient patient care with the help of artificial intelligence.
• HepaFat-AI: An AI-trained device for automated, real-time, multi-metric measurement of liver fat. This tool aids in the assessment and management of liver conditions by providing a comprehensive analysis of liver fat levels.
• CardiacT2: A service that complements FerriScan by offering dual analysis for assessing heart iron loading. This is particularly useful for the comprehensive management of conditions that affect both the liver and the heart.
• HepaFat-Scan: A non-invasive MRI-based solution for assessing liver fat in liver tissue, providing valuable information for the diagnosis and monitoring of liver health.
• LiverSmart: A non-invasive MRI-based multi-parametric device that combines the functionalities of FerriSmart and HepaFat-AI into a consolidated report, offering a holistic view of liver health.

In addition to these innovative products, Resonance Health offers a comprehensive suite of services tailored for quantitative imaging measurements and Contract Research Organization (CRO) needs. These services include quality-assured image analysis, project and data management, issue resolution services, and collaboration with third-party laboratories for blood/sample collection and biochemical/lab safety assessments. Furthermore, the company's experience extends to design and protocol development, project management and monitoring, and supporting clinical trials in demonstrating drug efficacy and safety profiles. Resonance Health also provides phantoms for MRI machines, ensuring the accurate calibration and operation of these critical diagnostic tools.